These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry. Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A; Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925 [TBL] [Abstract][Full Text] [Related]
4. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128 [TBL] [Abstract][Full Text] [Related]
5. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. Friedman DJ; Parzynski CS; Varosy PD; Prutkin JM; Patton KK; Mithani A; Russo AM; Curtis JP; Al-Khatib SM JAMA Cardiol; 2016 Nov; 1(8):900-911. PubMed ID: 27603935 [TBL] [Abstract][Full Text] [Related]
6. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577 [TBL] [Abstract][Full Text] [Related]
7. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799 [TBL] [Abstract][Full Text] [Related]
8. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study. Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336 [TBL] [Abstract][Full Text] [Related]
9. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy. Francia P; Adduci C; Semprini L; Palano F; Santini D; Musumeci B; Santolamazza C; Volpe M; Autore C J Cardiovasc Electrophysiol; 2017 Jan; 28(1):103-108. PubMed ID: 27862589 [TBL] [Abstract][Full Text] [Related]
11. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018. Borne RT; Varosy P; Lan Z; Masoudi FA; Curtis JP; Matlock DD; Peterson PN JAMA Netw Open; 2022 Mar; 5(3):e223429. PubMed ID: 35315917 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion. Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316 [TBL] [Abstract][Full Text] [Related]
13. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
14. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project. Stefano B; Pietro RR; Maurizio G; Maurizio L; Renato M; Maurizio L; Pietro R; Alessandro P; Gianluca B; Monica M; Sergio C; Massimo S Am Heart J; 2011 Aug; 162(2):390-7. PubMed ID: 21835302 [TBL] [Abstract][Full Text] [Related]
16. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884 [TBL] [Abstract][Full Text] [Related]
17. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system]. Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649 [TBL] [Abstract][Full Text] [Related]
18. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can. Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177 [TBL] [Abstract][Full Text] [Related]
19. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K; JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115 [TBL] [Abstract][Full Text] [Related]
20. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II. Gradaus R; Block M; Seidl K; Brunn J; Isgro F; Hammel D; Hauer B; Breithardt G; Bocker D J Cardiovasc Electrophysiol; 2001 Aug; 12(8):921-7. PubMed ID: 11513444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]